The effect of compounds 1-5 on P-gp ATPase activity was measured using the Pgp-Glo™ assay system. Verapamil, a P-gp substrate and competitive inhibitor for other substrates, was used as a positive control. Sodium orthovanadate (Na3VO4), a selective inhibitor of P-gp ATPase, was used to account for P-gp-independent ATP consumption in the reactions. All compounds and controls were tested at either 40 μM or 200 μM (in 1% DMSO) as per the manufacturer's protocol. Sample luminescence was recorded after 50 min incubation with the ATP detection reagent using a luminometer (POLARstar Omega, BMG Labtech, Ortenberg, Germany). Change in luminescence in relative light units (RLU; RLUNa3VO4–RLUcompound) is inversely proportional to ATP levels, which are negatively correlated with the activity of P-gp ATPase and therefore P-gp-mediated transport.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.